阿玛琳 AMRN 深 沪
已收盘 12-19 16:00:00 美东时间
13.80
-0.030
-0.22%
华盛通- 最 高16.65
- 今 开13.83
- 成交量 13.83万股
- 最 低 13.41
- 昨 收 13.83
- 总市值 54.79亿
- 52周最高 20.90
- 市盈率 静 718.75
- 换手率 0.03%
- 52周最低 0.354
- 委 比 -7.32%
- 总股本 3.97亿
- 历史最高 26.12
- 量 比 1.35
- 振 幅 23.43%
- 历史最低 0.354
- 每 手 1
- 风险率 6.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Outlook For Amarin Corp
Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report o...
10-29 05:01
苹果、微软、亚马逊、Meta财报来袭
作者丨Oliver Rodzianko 编译 | 华尔街大事件 本周科技巨头、能源巨头、金融公司、医疗保健行业领袖和消费者品牌将陆续发布大量财报。 焦点将集中...
07-28 20:40
Amneal to Participate at Upcoming Investor Conferences in June
Amneal Pharmaceuticals will participate in the Jefferies Global Healthcare Conference on June 5 and Goldman Sachs Global Healthcare Conference on June 10, with executives presenting and a live webcast available.
05-29 20:05
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5%
11:10 AM EDT, 08/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Friday morning, nudging down 0.03% to 1,476.31 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and ...
2024-08-30 23:10
Amarin Shares Latest Research Highlighting VASCEPA/VAZKEPA REDUCE-IT Subgroup Data And New Mechanistic Insights Into Eicosapentaenoic Acid To Be Presented At ESC Congress 2024
Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT® cardiovascular outcomes trial with VASCEPA®/VAZKEPA® (icosapent ethyl), as well as abstracts showcasing the mechanistic activity of eicosapentaenoic acid (EPA) that will be pre...
2024-08-22 20:33
